Cargando…

Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome

IMPORTANCE: Many older adults with depression do not experience remission with antidepressant treatment, and markers of cellular senescence in late-life depression (LLD) are associated with greater severity of depression, greater executive dysfunction, and higher medical illness burden. Since these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diniz, Breno S., Mulsant, Benoit H., Reynolds, Charles F., Blumberger, Daniel M., Karp, Jordan F., Butters, Meryl A., Mendes-Silva, Ana Paula, Vieira, Erica L., Tseng, George, Lenze, Eric J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247739/ https://www.ncbi.nlm.nih.gov/pubmed/35771573 http://dx.doi.org/10.1001/jamanetworkopen.2022.19678

Ejemplares similares

Mild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adults
por: Diniz, Breno S., et al.
Publicado: (2021)

Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapy
por: Lissemore, Jennifer I., et al.
Publicado: (2021)

Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depression
por: Lin, Chemin, et al.
Publicado: (2019)

Recruiting for a randomized clinical trial for late-life depression during COVID-19: outcomes of provider referrals vs. Facebook self-referrals
por: Ainsworth, Nicholas, et al.
Publicado: (2023)

Pathways linking late-life depression to persistent cognitive impairment and dementia
por: Butters, Meryl A., et al.
Publicado: (2008)

Exploratory genome-wide analyses of cortical inhibition, facilitation, and plasticity in late-life depression
por: Wathra, Rafae A., et al.
Publicado: (2023)

Acute trajectories of neural activation predict remission to pharmacotherapy in late-life depression
por: Karim, Helmet T., et al.
Publicado: (2018)

Plasma Biosignature and Brain Pathology related to Persistent Cognitive Impairment in Late-Life Depression
por: Diniz, Breno S., et al.
Publicado: (2014)

Evidence for Structural and Functional Alterations of Frontal-Executive and Corticolimbic Circuits in Late-Life Depression and Relationship to Mild Cognitive Impairment and Dementia: A Systematic Review
por: Rashidi-Ranjbar, Neda, et al.
Publicado: (2020)

Telomere shortening in late‐life depression: A potential marker of depression severity
por: Mendes‐Silva, Ana Paula, et al.
Publicado: (2021)

Recruiting for a Randomized Clinical Trial for Late-Life Depression During COVID-19: Outcomes of Provider Referrals Versus Facebook Self-Referrals
por: Ainsworth, Nicholas J., et al.
Publicado: (2023)

Incomplete response in late-life depression: getting to remission
por: Lenze, Eric J., et al.
Publicado: (2008)

Psychosocial Risk Factors for Cognitive Decline in Late-Life Depression: Findings from the MTLD-III Study
por: Rej, Soham, et al.
Publicado: (2015)

Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults: A Systematic Review and Meta-analysis
por: Jones, Brett D. M., et al.
Publicado: (2021)

Magnetic Seizure Therapy for Suicidality in Treatment-Resistant Depression
por: Weissman, Cory R., et al.
Publicado: (2020)

Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response
por: Marshe, Victoria S., et al.
Publicado: (2021)

Major depression and enhanced molecular senescence abnormalities in young and middle-aged adults
por: Diniz, Breno S., et al.
Publicado: (2019)

Intrinsic functional connectivity in late-life depression: trajectories over the course of pharmacotherapy in remitters and non-remitters
por: Karim, H T, et al.
Publicado: (2017)

Physical activity and brain plasticity in late adulthood
por: Erickson, Kirk I., et al.
Publicado: (2013)

A cross-sectional study of cognitive performance in bipolar disorder across the lifespan: the cog-BD project
por: Jones, Brett D. M., et al.
Publicado: (2023)

Experiences of American Older Adults with Pre-existing Depression During the Beginnings of the COVID-19 Pandemic: A Multicity, Mixed-Methods Study
por: Hamm, Megan E., et al.
Publicado: (2020)

Applications of magnetic resonance imaging for treatment-resistant late-life depression
por: Agudelo, Christian, et al.
Publicado: (2015)

Low-Dose Augmentation With Buprenorphine for Treatment-Resistant Depression: A Multisite Randomized Controlled Trial With Multimodal Assessment of Target Engagement
por: Lee, Hyewon H., et al.
Publicado: (2021)

Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression: The FOUR-D Randomized Noninferiority Clinical Trial
por: Blumberger, Daniel M., et al.
Publicado: (2022)

Plasma IL-17A levels in patients with late-life depression
por: Saraykar, Smita, et al.
Publicado: (2017)

Enhancing Cognition in Older Persons with Depression or Anxiety with a Combination of Mindfulness-Based Stress Reduction (MBSR) and Transcranial Direct Current Stimulation (tDCS): Results of a Pilot Randomized Clinical Trial
por: Brooks, Heather, et al.
Publicado: (2021)

Genetic Basis of Increased Lifespan and Postponed Senescence in Drosophila melanogaster
por: Parker, Grace A., et al.
Publicado: (2020)

Differentiating the Cognitive Profile of Schizophrenia from That of Alzheimer Disease and Depression in Late Life
por: Ting, Christina, et al.
Publicado: (2010)

Late-life depression and increased risk of dementia: a longitudinal cohort study
por: Ly, M., et al.
Publicado: (2021)

Developmental trajectories of body mass index from childhood into late adolescence and subsequent late adolescence–young adulthood cardiometabolic risk markers
por: Oluwagbemigun, Kolade, et al.
Publicado: (2019)

The Length of the Shortest Telomere as the Major Determinant of the Onset of Replicative Senescence
por: Xu, Zhou, et al.
Publicado: (2013)

Defining the consequences of endogenous genetic variation within a novel family of Schizosaccharomyces pombe heterochromatin nucleating sequences
por: Joshi, Arati, et al.
Publicado: (2021)

Placebo response in treatment resistant depression: a systematic review and meta-analysis of multiple treatment modalities
por: Jones, Brett D M, et al.
Publicado: (2021)

Efficacy of Blended Collaborative Care for Patients With Heart Failure and Comorbid Depression: A Randomized Clinical Trial
por: Rollman, Bruce L., et al.
Publicado: (2021)

Assessing the Role of Past Depression in Patients with Mild Cognitive Impairment, with and without Biomarkers for Alzheimer’s Disease
por: Golas, Angela C., et al.
Publicado: (2023)

Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data
por: Weissman, Cory R., et al.
Publicado: (2021)

KRAS Sequence Variation as Prognostic Marker in Patients With Young- vs Late-Onset Colorectal Cancer
por: Aljehani, Mayada A., et al.
Publicado: (2023)

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
por: Husain, Muhammad Ishrat, et al.
Publicado: (2023)

Genome-Wide Analysis to Identify Pathways Affecting Telomere-Initiated Senescence in Budding Yeast
por: Chang, Hsin-Yu, et al.
Publicado: (2011)

Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification
por: MORENO, Sara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g5cq940187k7d481gogbh4ualn